Application of RNAi in gene-deficient models

Acta Genetica Sinica

Volumn 32, Issue 4, 2005, Pages 434-441

  Tan, Yu Liang ^a   Yin, Qin Wei ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

Author keywords

dsRNA; Gene silencing; Gene deficient models; RNAi; siRNA

Indexed keywords

DOUBLE STRANDED RNA; MESSENGER RNA;

ARTICLE; CANCER; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GENE THERAPY; GENETIC DISORDER; HUMAN; HUMAN CELL; MAMMAL CELL; METABOLIC DISORDER; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TECHNOLOGY; VIRUS INFECTION;

ANIMALS; FRAGILE X SYNDROME; GENE THERAPY; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 20044365240     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fire A, Xu S, Montgomery M K, Kostas S A, Driver S E, Mello C C. Potent and specific genetics interference by double-stranded RNA in Caenorhabitis elegans. Nature, 1998, 391(6669): 806-811.
2. Jorgensen R. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol, 1990, 8(12): 340-344.
3. Romano N, Macino G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol, 1992, 6(22): 3343-3353.
4. Zamore P D, Tuschl T, Sharp P A, Bartel D P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 2000, 101(1): 25-33.
5. Yin J Q, Wang Y. RNA-mediated gene regulation system: now and the future. Int J Mol Med, 2002, 10(4): 355-365.
6. Kelly K H, Stephan A V. Hurdles and Hopes for Cancer Treatment. Science, 2002, 297(5580): 415-416.
7. McManus M T, Sharp P A. Gene silencing in mammals by small interfering RNAs. Nat Rev Mol Cell Biol, 2002, 3 (10): 737-747.
8. Elbashir S M, Lendeckel W, Tuschl T. RNA interference is mediate by 21- and 22-nucleotide RNAs. Genes Dev, 2001, 15(2): 188-200.
9. Bernstein E, Caudy A A, Hammond S M, Hannon G J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 2001, 409(6818): 363-366.
10. Nykanes A, Haley B, Zamore P D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell, 2001, 107(3): 309-321.
11. Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411 (6836): 494-498.
12. Doench J G, Petersen C P, Sharp P A. siRNAs can function as miRNAs. Genes Dev, 2003, 17(4): 438-442.
13. Zeng Y, Yi R, Cullen B R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA, 2003, 100(17): 9779-9784.
14. Pal-Bhadra M, Bhadra U, Birchler J. A RNAi related mechanisms affect both transcriptional and posttranscriptional transgene silencing in Drosophila. Mol Cell, 2002, 9(2): 315-327.
15. Mette M F, Aufsatz W, van der Winden J, Matzke M A, Matzke A J. Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J, 2000, 19 (9): 5194-5201.
16. Mochizuki K, Fine N A, Fujisawa T, Gorovsky M A. Analysis of a piwi related gene implicates small RNAs in genome rearrangement in tetrahymena. Cell, 2002, 110(6): 689-699.
17. Paule M R, White R J. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res, 2000, 28 (6): 1283-1298.
18. Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol, 2002, 20(5): 497-500.
19. Kwak Y D, Koike H, Sugaya K. RNA Interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J Pharmacol Sci, 2003, 93(2): 214-217.
20. Tiscornia G, Singer O, Ikawa M, Verma I M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA, 2003, 100(4): 1844-1848.
21. Myslinski E, Ame J C, Krol A, Carbon P. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res, 2001, 29 (12): 2502-2509.
22. Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, Fisch G, Leenders F, Arnold W, Giese K, Klippel A, Kaufmann J. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res, 2003, 31 (21): 127-135.
23. Wassarman D A, Steitz J. A structural analysis of the 7SK ribonucleoprotein (RNP), the most abundant human small RNP of unknown function. Mol Cell Biol, 1991, 11(7): 3432-3445.
24. Blencowe B J. Transcription: surprising role for an elusive small nuclear RNA. Curr Biol, 2002, 12(4): 147-149.
25. Val promoter significantly induce RNAi-mediated gene siliencing in the cytoplasm of human cells. Nucleic Acids Res, 2003, 31(2): 700-707.
26. Yang S, Tutton S, Yoon K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol, 2001, 21(22): 7807-7816.
27. Yin J Q, Cao J S, Shao R G, Tian W N, Wang J P, Wan Y S. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Onc, 2003, 3(4): 194-204.
28. Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol, 2003, 21(5): 559-561.
29. Shen C, Buck A K, Liu X, Winkler M, Reske S N. Gene silencing by adenovirus-delivered siRNA. FEBS Lett, 2003, 539(1-3): 111-114.
30. Hemann M T, Fridman J S, Zilfou J T, Hernando E, Paddison P J, Cordon-Cardo C, Hannon G J, Lowe S W. An epiallelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in invo. Nat Genet, 2003, 33: 396-400.
31. Rubinson D A, Dillon C P, Kwiatkowski A V, Sievers C, Yang L, Kopinja J, Rooney D L, Ihrig M M, McManus M T, Gertler F B, Scott M L, van Parijs L. A lentivirus-delivered system to silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33(3): 401-406.
32. Qin X F, An D S, Chen I S, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediate system delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA, 2003, 100(1): 183-188.
33. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, de Villartay J P, Thrasher A J, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies E G, Kuis W, Leiva L, Cavazzana-Calvo M. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med, 2002, 346(16): 1185-1193.
34. Brummekamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296(5567): 550-553.
35. Lichner Z, Silhavy D, Burgyan J. Double-stranded RNA-binding proteins could suppress RNA interference-mediate antiviral defenses. J Gen Virol, 2003, 84(4): 975-980.
36. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol. 2002, 169(9): 5196-5201.
37. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov, 2004, 3(4): 318-29.
38. Ishizuka A, Siomi M C, Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev, 2002, 16(19): 2497-2508.
39. Stoll C. Problems in the diagnosis of fragile X syndrome in young children are still present. Am J Med Genet, 2001, 100(2): 110-115.
40. Qin M, Kang J, Smith C B. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Nat Acad Sci USA, 2002, 99(24): 15758-15763.
41. Muqit M M, Feany M B. Modelling neurodegenerative diseases in Drosophila: A fruitful approach? Nat Rev Neurosci, 2002, 3(3): 237-243.
42. Jin P, Zarnescu D C, Ceman S, Nakamoto M, Mowrey J, Jongens T A, Nelson D L, Moses K, Warren S T. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci, 2004, 7(2): 113-117.
43. Gleeson J G, Allen K M, Fox J W, Lamperti E D, Berkovic S, Scheffer I, Cooper E C, Dobyns W B, Minnerath S R, Ross M E, Walsh C A. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell, 1998, 92(1): 63-72.
44. Shmueli O, Gdalyahu A, Sorokina K, Nevo E, Avivi A, Reiner O. DCX in PC12 cells: CREB-mediated transcription and neurite outgrowth. Hum Mol Genet, 2001, 10(10): 1061-1070.
45. Bai J, Ramos R L, Ackman J B, Thomas A M, Lee R V, Lo-Turco J J. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci, 2003, 6(12): 1277-1283.
46. Schmitt C A, Fridman J S, Yang M, Baranov E, Hoffman R M, Lowe S W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell, 2002, 1(3): 289-298.
47. Mancama D, Arranz M J, Kerwin R W. Pharmacogenomics of psychiatric drug treatment. Curr Opin Mol Ther, 2003, 5 (6): 642-649.
48. Dawson T D, Dawson V L. Molecular pathways of neurodegeneration in Parkinson's disease. Science, 2003, 302 (5646): 819-822.
49. Hommel J D, Sears R M, Georgescu D, Simmons D L, DiLeone R J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med. 2003, 9(12): 1539-1544.
50. Drive G, Hernandez R M, Rodriguez G A, Dominguez-Gil A, Pedraz J L. Drug delivery in biotechnology: present and future. Cur Opin in Biotechnol, 2003, 14(6): 659-664.
51. Paddison P J, Silva J M, Conklin D S, Schlabach M, Li M, Aruleba S, Balija V, O'Shaughnessy A, Gnoj L, Scobie K, Chang K, Westbrook T, Cleary M, Sachidanandam R, McCombie W R, Elledge S J, Hannon G J. A resource for large-scale RNA-interference-based screens in mammals. Nature, 2004, 428(6981): 427-431.